Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment
Xiaohua Li,1 Dalin Song,2 Sean X Leng31Dalian Medical University, Dalian, 2Department of Geriatrics, Qingdao Municipal Hospital, Qingdao, People’s Republic of China; 3Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine, Baltim...
Guardado en:
| Autores principales: | , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Dove Medical Press
2015
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/e088bc2e14f3470a93eb113971a55f06 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:e088bc2e14f3470a93eb113971a55f06 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:e088bc2e14f3470a93eb113971a55f062021-12-02T11:46:11ZLink between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment1178-1998https://doaj.org/article/e088bc2e14f3470a93eb113971a55f062015-03-01T00:00:00Zhttps://www.dovepress.com/link-between-type-2-diabetes-and-alzheimerrsquos-disease-from-epidemio-peer-reviewed-article-CIAhttps://doaj.org/toc/1178-1998Xiaohua Li,1 Dalin Song,2 Sean X Leng31Dalian Medical University, Dalian, 2Department of Geriatrics, Qingdao Municipal Hospital, Qingdao, People’s Republic of China; 3Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USAAbstract: The aim of this paper is to provide a comprehensive review of the epidemiological evidence linking type 2 diabetes mellitus and its related conditions, including obesity, hyperinsulinemia, and metabolic syndrome, to Alzheimer’s disease (AD). Several mechanisms could help to explain this proposed link; however, our focus is on insulin resistance and deficiency. Studies have shown that insulin resistance and deficiency can interact with amyloid-ß protein and tau protein phosphorylation, each leading to the onset and development of AD. Based on those epidemiological data and basic research, it was recently proposed that AD can be considered as “type 3 diabetes”. Special attention has been paid to determining whether antidiabetic agents might be effective in treating AD. There has been much research both experimental and clinical on this topic. We mainly discuss the clinical trials on insulin, metformin, thiazolidinediones, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors in the treatment of AD. Although the results of these trials seem to be contradictory, this approach is also full of promise. It is worth mentioning that the therapeutic effects of these drugs are influenced by the apolipoprotein E (APOE)-ε4 genotype. Patients without the APOE-ε4 allele showed better treatment effects than those with this allele.Keywords: type 2 diabetes mellitus, Alzheimer’s disease, insulinA Letter to Editor has been received and published for this articleLi XHSong DLLeng SXDove Medical PressarticleAlzheimer's diseasediabetes mellitusinsulinGeriatricsRC952-954.6ENClinical Interventions in Aging, Vol Volume 10, Pp 549-560 (2015) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Alzheimer's disease diabetes mellitus insulin Geriatrics RC952-954.6 |
| spellingShingle |
Alzheimer's disease diabetes mellitus insulin Geriatrics RC952-954.6 Li XH Song DL Leng SX Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment |
| description |
Xiaohua Li,1 Dalin Song,2 Sean X Leng31Dalian Medical University, Dalian, 2Department of Geriatrics, Qingdao Municipal Hospital, Qingdao, People’s Republic of China; 3Division of Geriatric Medicine and Gerontology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USAAbstract: The aim of this paper is to provide a comprehensive review of the epidemiological evidence linking type 2 diabetes mellitus and its related conditions, including obesity, hyperinsulinemia, and metabolic syndrome, to Alzheimer’s disease (AD). Several mechanisms could help to explain this proposed link; however, our focus is on insulin resistance and deficiency. Studies have shown that insulin resistance and deficiency can interact with amyloid-ß protein and tau protein phosphorylation, each leading to the onset and development of AD. Based on those epidemiological data and basic research, it was recently proposed that AD can be considered as “type 3 diabetes”. Special attention has been paid to determining whether antidiabetic agents might be effective in treating AD. There has been much research both experimental and clinical on this topic. We mainly discuss the clinical trials on insulin, metformin, thiazolidinediones, glucagon-like peptide-1 receptor agonists, and dipeptidyl peptidase-4 inhibitors in the treatment of AD. Although the results of these trials seem to be contradictory, this approach is also full of promise. It is worth mentioning that the therapeutic effects of these drugs are influenced by the apolipoprotein E (APOE)-ε4 genotype. Patients without the APOE-ε4 allele showed better treatment effects than those with this allele.Keywords: type 2 diabetes mellitus, Alzheimer’s disease, insulinA Letter to Editor has been received and published for this article |
| format |
article |
| author |
Li XH Song DL Leng SX |
| author_facet |
Li XH Song DL Leng SX |
| author_sort |
Li XH |
| title |
Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment |
| title_short |
Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment |
| title_full |
Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment |
| title_fullStr |
Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment |
| title_full_unstemmed |
Link between type 2 diabetes and Alzheimer’s disease: from epidemiology to mechanism and treatment |
| title_sort |
link between type 2 diabetes and alzheimer’s disease: from epidemiology to mechanism and treatment |
| publisher |
Dove Medical Press |
| publishDate |
2015 |
| url |
https://doaj.org/article/e088bc2e14f3470a93eb113971a55f06 |
| work_keys_str_mv |
AT lixh linkbetweentype2diabetesandalzheimerrsquosdiseasefromepidemiologytomechanismandtreatment AT songdl linkbetweentype2diabetesandalzheimerrsquosdiseasefromepidemiologytomechanismandtreatment AT lengsx linkbetweentype2diabetesandalzheimerrsquosdiseasefromepidemiologytomechanismandtreatment |
| _version_ |
1718395256722948096 |